The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma

Laryngoscope

Volumn 122, Issue 4, 2012, Pages 826-833

  De Virgilio, Armando ^a   Fusconi, Massimo ^a   Gallo, Andrea ^a   Greco, Antonio ^a   Kim, Se Heon ^b   Conte, Michela ^a   Alessi, Simone ^a   Tombolini, Mario ^a   De Vincentiis, Marco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

advanced; carcinoma; laryngectomy; Larynx; subtotal

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRICOHYOIDOPEXY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX SURGERY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NASOGASTRIC TUBE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURGICAL INFECTION; SURVIVAL TIME; TRACHEOSTOMY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CRICOID CARTILAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862786235     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23178     Document Type: Article

References (19)

1. De Vincentiis M, Minni A, Gallo A, et al. Supracricoid partial laryngectomies: oncologic and functional results. Head Neck 1998; 20: 504-509.
2. Farrag TY, Koch WM, Cummings CW, et al. Supracricoid laryngectomy outcomes: The Johns Hopkins experience. Laryngoscope 2007; 117: 129-132.
3. De Vincentiis M, Minni A, Gallo A,. Supracricoid laryngectomy with cricohyoidopexy (CHP) in the treatment of laryngeal cancer: a functional and oncologic experience. Laryngoscope 1996; 106: 1108-1114.
4. Laccourreye O, Brasnu D, Biacabe B, et al. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 1998; 20: 595-599.
5. Karasalihoglu AR, Yagiz R, Tas A, et al. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results. J Laryngol Otol 2004; 118: 671-675.
6. Cho KJ, Joo YH, Sun DI, et al. Supracricoid laryngectomy: oncologic validity and functional safety. Eur Arch Otorhinolaryngol 2010; 267: 1919-1925.
7. Soudry E, Marmor Y, Hazan A, et al. Supracricoid partial laryngectomy: an alternative to total laryngectomy for locally advanced laryngeal cancers. J Laryngol Otol 2008; 122: 1219-1223.
8. Labayle J,. Partial surgery of the larynx: current state of the question. Rev Laryngol Otol Rhinol 1970; 91: 495-510.
9. Majer EH, Rieder W,. Technique de laryngectomie permettant de conserver la permeabilite respiratoire: la crico-hyoido-pexie [in French]. Ann Otolaryngol Chir Cervicofac 1959; 76: 677-683.
10. Piquet JJ, Desaulty A, Decroix G,. Crico-hyoido-epiglotto-pexy. Surgical technic and functional results. Ann Otolaryngol Chir Cervicofac 1974; 91: 681-686.
11. Bridger GP,. Supracricoid partial laryngectomy with cricohyoidopexy for advanced laryngeal cancer. Aust J Otolaryngol 1996; 2: 400-402.
12. Dufour X, Hans S, De Mones E, et al. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004; 130: 1092-1099.
13. Lima RA, Freitas EQ, Dias FL, et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy for advanced glottic cancer. Head Neck 2006; 28: 481-486.
14. Fusconi M, Gallo A, Vitiello C, et al. Clean-contaminated neck surgery: risk of infection by intrinsic and extrinsic factors. Arch Otolaryngol Head Neck Surg 2006; 132: 953-957.
15. Gale N, Michaels L, Luzar B, et al. Current review on squamous intraepithelial lesions of the larynx. Histopathology 2009; 54: 639-656.
16. Almadori G, Bussu F, Cadoni G, et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005; 41: 683-693.
17. Leemans CR, Tiwari R, Nauta O, et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71: 452-456.
18. Hensen EF, De Herdt MJ, Goeman JJ, et al. Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysis. BMC Cancer 2008; 8: 168.
19. Yilmaz T, Hosal AS, Gedikoglu G, et al. Prognostic significance of vascular and perineural invasion in cancer of the larynx. Am J Otolaryngol 1998; 19: 83-88.